News / Health

Tuberculosis 'Time Bomb' Costs Europe Billions Annually

Belarusians queue for X-rays to detect tuberculosis during Belarusian Red Cross screening, Minsk, Jan. 29, 2013.
Belarusians queue for X-rays to detect tuberculosis during Belarusian Red Cross screening, Minsk, Jan. 29, 2013.
Reuters
Europe is facing a multi-billion-euro time bomb of rising costs to control tuberculosis (TB) as drug-resistant forms of the lung disease spread, a pioneering study found.
 
Often thought of as a disease of the past or one restricted to marginalized communities, TB is already inflicting annual direct costs of more than 500 million euros on the region and another 5.3 billion euros in productivity losses.
 
The study, by health economists based in Germany, also suggests the economic burden of TB far outweighs the likely costs of investing in much-needed research to develop more effective medicines and vaccines — something they said governments and the drug industry should do urgently.
 
"We know that new drugs and vaccines are very expensive [to develop], but if you take these costs into consideration, then everything is justified," said Roland Diel, a health economics professor at Germany's University Hospital Schleswig-Holstein in Kiel, who led the study.
 
The emergence of strains of that can't be treated with even the most powerful of drugs has turned TB into one of the world's most pressing health problems.
 
According to the World Health Organization (WHO), TB infected 8.7 million people worldwide in 2011 and killed 1.4 million. As many as two million people may have drug-resistant strains by 2015, the Geneva-based health agency says.
 
Treating even typical TB is a long process. Patients need to take a cocktail of antibiotics for six months and many fail to complete the treatment. That, alongside overuse and misuse of antibiotics, has fuelled the emergence of multidrug-resistant TB (MDR-TB) and extensively drug resistant (XDR-TB).
 
For this study, published online in the European Respiratory Journal on Friday and the first of its kind, researchers used a systematic review of literature and institutional websites for the 27 EU member states to summarize data on TB treatment costs in 2011.
 
They split the countries into two groups based on gross domestic product (GDP) per person.
 
For the old EU 15 countries plus Cyprus, Malta and Slovenia, the average direct cost per case of typical TB was 10,282 euros ($13,600), but was more than 57,200 euros for MDR cases and more than 170,700 euros for XDR cases. For the remaining EU states, average costs were 3,427 euros for standard treatable TB and around 24,100 euros for drug-resistant cases.
 
The total treatment cost of all TB cases in 2011 was 536,890,315 euros ($712.26 million).
 
While the number of drug-resistant TB cases in Europe is currently only a tiny fraction of the total of around 70,000 cases per year, Diel said that would swiftly change.
 
"It's a time bomb in terms of drug-resistant cases," he said in a telephone interview. "They are just a small fraction right now, but that will increase... so the costs will also rise."
 
Beyond the direct costs, Diel's team also calculated TB's impact in terms of the monetary value of lost productivity.
 
Using disability-adjusted life years, or DALYs — a measure of disease burden that looks at the number of years lost due to ill-health, disability or early death — they found the total years lost was 103,104 in 2011. In monetary terms, this amounted to more than 5.3 billion euros.
 
Diel said this was the figure that shocked him the most.
 
"People assume that in most parts of Europe, TB doesn't play much of a role in comparison to other diseases. But, in fact, the costs of it are very high," he said. "It's billions, and nobody realized that before."
 
Responding to the findings, Francesco Blasi, President of the European Respiratory Society, said they showed the huge burden of TB on both the economy and on society in Europe.
 
"It is critical that healthcare professionals and policymakers take note," he said in a statement.

You May Like

Anti-Terror Drills Highlight China’s Push Into Central Asia

China, Russia, several central Asian countries wrap up massive anti terrorism military drills in Inner Mongolia More

Erdogan’s First Step: Secure More Power in New Role in Turkey

Erdogan was sworn in as Turkey's first popularly elected president on Thursday; he picked former foreign minister Ahmet Davutoglu as PM More

Pakistan Army Fails to Break Political Deadlock

PM Sharif claims he didn't ask army to defuse crisis; military rejects claim More

This forum has been closed.
Comments
     
There are no comments in this forum. Be first and add one

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Ukraine Battles Pro-Russia Rebel Assaulti
X
Daniel Schearf
August 29, 2014 9:30 PM
After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Ukraine Battles Pro-Russia Rebel Assault

After NATO concluded an emergency meeting to discuss the crisis in eastern Ukraine, the country is struggling to contain heavy fighting near the strategic port of Mariupol, on the Azov Sea. Separatist rebels are trying to capture the city, allegedly with Russian military help, and Ukraine's defense forces are digging in. VOA's Daniel Schearf spoke with analysts about what lies ahead for Ukraine.
Video

Video Growing Business Offers Paint with a Twist of Wine

Two New Orleans area women started a small business seven years ago with one thing in mind: to help their neighbors relieve the stress of coping with a hurricane's aftermath. Today their business, which pairs painting and a little bit of wine, has become one of the fastest growing franchises across the U.S. VOA’s June Soh met the entrepreneurs at their newest franchise location in the Washington suburbs.
Video

Video Ebola Vaccine Trials To Begin Next Week

The National Institutes of Health says it is launching early stage trials of a vaccine to prevent the Ebola virus, which has infected or killed thousands of people across West Africa. The World Health Organization says Ebola could infect more than 20,000 people across the region by the time the outbreak is over. The epidemic has health experts and governments scrambling to prevent more people from becoming infected. Zlatica Hoke has more.
Video

Video Asian Bacteria Threatens Florida Orange Trees

Florida's citrus fruit industry is facing a serious threat from a bacteria carried by the Asian insect called psyllid. The widespread infestation again highlights the danger of transferring non-native species to American soil. VOA’s George Putic reports.
Video

Video Aging Will Reduce Economic Growth Worldwide in Coming Decades

The world is getting older, fast. And as more people retire each year, fewer working-age people will be there to replace them. Bond rating agency Moody’s says that will lead to a decline in household savings; reducing global investments - which in turn, will lead to slower economic growth around the world. But experts say it’s not too late to mitigate the economic impact of the world’s aging populations. Mil Arcega has more.
Video

Video Is West Doing Enough to Tackle Islamic State?

U.S. President Barack Obama has ruled out sending ground troops to Iraq to fight militants of the so-called Islamic State, or ISIS, despite officials in Washington describing the extremist group as the biggest threat the United States has faced in years. Henry Ridgwell reports from London on the growing uncertainty over whether the West’s response to ISIS will be enough to defeat the terrorist threat.
Video

Video Coalition to Fight Islamic State Could Reward Assad

The United States along with European and Mideast allies are considering a broader assault against Islamic State fighters who have spread from Syria into Iraq and risk further destabilizing an already troubled region. But as VOA State Department Correspondent Scott Stearns reports, confronting those militants could end up helping the embattled Syrian President Bashar al-Assad.
Video

Video Made in America Socks Get Toehold in Online Fashion Market

Three young entrepreneurs are hoping to revolutionize the high-end sock industry by introducing all-American creations of their own. And they’re doing most of it the old-fashioned way. VOA’s Julie Taboh recently caught up with them to learn what goes into making their one-of-a-kind socks.
Video

Video Americans, Ex-Pats Send Relief Supplies to West Africa

Health organizations from around the world are sending supplies and specialists to the West African countries that are dealing with the worst Ebola outbreak in history. On a smaller scale, ordinary Americans and African expatriates living in the United States are doing the same. VOA's Carol Pearson reports.
Video

Video America's Most Popular Artworks Displayed in Public Places

Public places in cities across America were turned into open-air art galleries in August. Pictures of the nation’s most popular artworks were displayed on billboards, bus shelters, subway platforms and more. The idea behind “Art Everywhere,” a collaborative campaign by five major museums is to allow more people to enjoy art and learn about the country’s culture and history. Faiza Elmasry has more.
Video

Video Chinese Doctors Use 3-D Spinal Implant

A Chinese boy suffering from a debilitating bone disease has become the first patient with a part of his spine created in a three-dimensional printer. Doctors say he will soon regain normal mobility. VOA’s George Putic reports.
Video

Video India’s Leprosy Battle Stymied by Continuing Stigma

Medical advancements in the treatment of leprosy have greatly diminished its impact around the world, largely eliminating the disease from most countries. India made great strides in combating leprosy, but still accounts for a majority of the world’s new cases each year, and the number of newly infected Indians is rising - more than 130,000 recorded last year. Doctors there say the problem has more to do with society than science. Shaikh Azizur Rahman reports from Kolkata.

AppleAndroid